Functional characterization and immunomodulatory properties of Lactobacillus helveticus strains isolated from Italian hard cheeses.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
21
10
2020
accepted:
09
01
2021
entrez:
25
1
2021
pubmed:
26
1
2021
medline:
25
6
2021
Statut:
epublish
Résumé
Lactobacillus helveticus carries many properties such as the ability to survive gastrointestinal transit, modulate the host immune response, accumulate biopeptides in milk, and adhere to the epithelial cells that could contribute to improving host health. In this study, the applicability as functional cultures of four L. helveticus strains isolated from Italian hard cheeses was investigated. A preliminary strain characterization showed that the ability to produce folate was generally low while antioxidant, proteolytic, peptidase, and β-galactosidase activities resulted high, although very variable, between strains. When stimulated moDCs were incubated in the presence of live cells, a dose-dependent release of both the pro-inflammatory cytokine IL-12p70 and the anti-inflammatory cytokine IL-10, was shown for all the four strains. In the presence of cell-free culture supernatants (postbiotics), a dose-dependent, decrease of IL-12p70 and an increase of IL-10 was generally observed. The immunomodulatory effect took place also in Caciotta-like cheese made with strains SIM12 and SIS16 as bifunctional (i.e., immunomodulant and acidifying) starter cultures, thus confirming tests in culture media. Given that the growth of bacteria in the cheese was not necessary (they were killed by pasteurization), the results indicated that some constituents of non-viable bacteria had immunomodulatory properties. This study adds additional evidence for the positive role of L. helveticus on human health and suggests cheese as a suitable food for delivering candidate strains and modulating their anti-inflammatory properties.
Identifiants
pubmed: 33493208
doi: 10.1371/journal.pone.0245903
pii: PONE-D-20-33078
pmc: PMC7833162
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0245903Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Benef Microbes. 2017 Aug 24;8(4):597-604
pubmed: 28555501
Crit Rev Food Sci Nutr. 2016 Dec 9;56(16):2617-27
pubmed: 25629711
J Appl Microbiol. 2019 Jul;127(1):219-229
pubmed: 30973185
Int Immunopharmacol. 2012 Sep;14(1):39-46
pubmed: 22735758
PLoS One. 2014 Feb 10;9(2):e87615
pubmed: 24520333
Biotechnol J. 2007 Apr;2(4):426-34
pubmed: 17407210
BMC Microbiol. 2009 Mar 05;9:50
pubmed: 19265535
J Dairy Sci. 2010 Oct;93(10):4435-54
pubmed: 20854978
J Dairy Sci. 2008 Nov;91(11):4129-37
pubmed: 18946116
J Dairy Sci. 1996 Dec;79(12):2112-20
pubmed: 9029350
Gut. 2019 Nov;68(11):2080-2091
pubmed: 31427404
Food Chem. 2014 Aug 1;156:264-70
pubmed: 24629967
Front Microbiol. 2013 Mar 05;4:30
pubmed: 23467265
J Food Sci. 2015 Jun;80(6):S1352-9
pubmed: 25962497
Front Microbiol. 2012 Nov 19;3:392
pubmed: 23181058
J Dairy Res. 2009 Feb;76(1):98-104
pubmed: 19121230
J Appl Microbiol. 2007 Jan;102(1):106-15
pubmed: 17184325
PLoS One. 2009 Sep 16;4(9):e7056
pubmed: 19756155
Appl Environ Microbiol. 2003 Jun;69(6):3238-43
pubmed: 12788721
Genes Nutr. 2011 Aug;6(3):261-74
pubmed: 21499799
J Appl Microbiol. 2004;96(2):223-9
pubmed: 14723683
Benef Microbes. 2013 Mar 1;4(1):101-7
pubmed: 23271068
Anaerobe. 2012 Aug;18(4):386-91
pubmed: 22579985
Gut. 2012 Jul;61(7):1007-15
pubmed: 22301383
Front Endocrinol (Lausanne). 2017 Nov 23;8:315
pubmed: 29218028
J Appl Microbiol. 2010 Oct;109(4):1370-8
pubmed: 20497276
Appl Environ Microbiol. 2003 Aug;69(8):4542-8
pubmed: 12902240